CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus

New research at ACR Convergence 2023, the American College of Rheumatology’s annual meeting, demonstrates that CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus while maintaining a robust response to vaccines.

Immune-Onc’s antibody therapy collects second FDA orphan designation – Pharmaceutical Technology

Share this article IO-202 is a monoclonal antibody that targets leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), which can suppress immunity in solid tumours.

February 22, 2024

Safety Intelligence is Redefining How Pharmacovigilance Teams Operate

Beena Wood, Senior VP of Product Management, Safety and Medical Affairs, ArisGlobal The future of safety intelligence is now. New safety reporting and analytics advancements

August 3, 2023

Study examines oral hygiene self-care behavior among patients with mental health disorders

A study aiming to examine oral hygiene self-care behavior among patients with self-reported mental health disorders was presented at the 102nd General Session of the

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.